Finance ❯ Stock Market ❯ Investor Relations

Market Capitalization

Securities Fraud Shareholder Rights Nvidia

ImmunityBio Investor Lawsuits Push Toward May 26 Lead-Plaintiff Deadline

The filings follow an FDA warning about overstated claims for the cancer drug Anktiva.

ImmunityBio Securities Fight Intensifies After FDA Rebuke Over Anktiva Claims

Investor Lawsuits Build After FDA Rebukes ImmunityBio Over Anktiva Promotion

Securities Class Action Filed Against ImmunityBio After FDA Flags Anktiva Marketing

ImmunityBio Faces Growing Securities Suits After FDA Flags Misleading Anktiva Claims